Stay updated on Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Updated two location entries from Napoli, Italy, 80131 and 87100 to Naples, Italy, 80131 and 87100.
    Difference
    0.1%
    Check dated 2026-03-25T21:24:37.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T18:00:46.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T18:32:43.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Fallopian tube cancer was added to the eligible conditions in the study description. The study now targets FRα-expressing tumors across ovarian, primary peritoneal, and fallopian tube cancers.
    Difference
    0.0%
    Check dated 2026-02-18T07:25:05.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added to the site. The previous Revision: v3.4.1 entry and the outdated government operating-status notice were removed; no changes to the study content.
    Difference
    0.2%
    Check dated 2026-02-11T09:27:59.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Notice about government funding lapse and NIH operating status was added. The site revision indicator changed from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T05:50:33.000Z thumbnail image

Stay in the know with updates to Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page.